Pathstone Family Office’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-24,687
Closed -$2.23M – 1045
2021
Q4
$2.23M Buy
24,687
+626
+3% +$53.1K 0.06% 174
2021
Q3
$1.88M Buy
24,061
+2,108
+10% +$159K 0.05% 174
2021
Q2
$1.58M Buy
21,953
+2,334
+12% +$170K 0.05% 183
2021
Q1
$1.34M Buy
19,619
+19,136
+3,962% +$1.33M 0.05% 171
2020
Q4
$35K Buy
483
+471
+3,925% +$34.2K ﹤0.01% 587
2020
Q3
$1K Hold
12
– – ﹤0.01% 778
2020
Q2
$1K Sell
12
-100
-89% -$7.12K ﹤0.01% 698
2020
Q1
$7K Buy
+112
New +$6.84K ﹤0.01% 592
2019
Q2
– Sell
-87
Closed -$5K – 960
2019
Q1
$5K Hold
87
– – ﹤0.01% 613
2018
Q4
$5K Buy
+87
New +$4.97K ﹤0.01% 387

Other funds holding CONE

Pathstone Family Office's CONE Position: Q1 2022 in Review

Pathstone Family Office sold out of CyrusOne Inc Common Stock (CONE) in Q1 2022, closing a stake of 24,687 shares — an estimated $2.23M sold.

Pathstone Family Office first reported a position in CONE in Q4 2018 and held it in 10 quarters. The position peaked at $2.23M in Q4 2021. 3 funds tracked by Wall St. Rank hold CONE as of Q1 2022.

  • Pathstone Family Office reported no remaining CyrusOne Inc Common Stock position as of Q1 2022 after selling out during the quarter.
  • Pathstone Family Office sold 24,687 CyrusOne Inc Common Stock shares in Q1 2022, an estimated $2.23M.
  • Pathstone Family Office first reported a position in CyrusOne Inc Common Stock in Q4 2018 and held it in 10 quarters.
  • Pathstone Family Office's CyrusOne Inc Common Stock position peaked at $2.23M in Q4 2021.
  • 3 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2022.

Based on Pathstone Family Office's 13F filing for Q1 2022, filed 16 May 2022.